In ASCVD, moderate-intensity statin plus ezetimibe was noninferior to high-intensity statin alone at 3 y

被引:0
|
作者
Kelsey, Michelle D. [1 ]
Newby, L. Kristin
机构
[1] Duke Univ, Durham, NC 27708 USA
关键词
D O I
10.7326/J22-0085
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:JC126 / JC126
页数:1
相关论文
共 50 条
  • [31] Moderate-Intensity Statins Plus Ezetimibe vs. High-Intensity Statins After Coronary Revascularization: A Cohort Study
    Kim, Juwon
    Kang, Danbee
    Park, Hyejeong
    Kang, Minwoong
    Choi, Ki Hong
    Park, Taek Kyu
    Lee, Joo Myung
    Yang, Jeong Hoon
    Song, Young Bin
    Choi, Jin-Ho
    Choi, Seung-Hyuk
    Gwon, Hyeon-Cheol
    Guallar, Eliseo
    Cho, Juhee
    Hahn, Joo-Yong
    CARDIOVASCULAR DRUGS AND THERAPY, 2023, 37 (01) : 141 - 150
  • [32] The clinical effectiveness and safety of low/moderate-intensity statins & ezetimibe combination therapy vs. high-intensity statin monotherapy: a systematic review and meta-analysis
    Sydhom, Pishoy
    Al-Quraishi, Bakr
    El-Shawaf, Mohamad
    Osman, Mohamed T.
    Naji, Nourhan
    Awwad, Nouran
    Shehata, Nahla
    Osama, Mostafa
    Sergany, Heba
    Maurice, Kerollos F.
    Sayed, Ahmed
    BMC CARDIOVASCULAR DISORDERS, 2024, 24 (01):
  • [33] Medium-intensity statin with ezetimibe versus high-intensity statin in acute ischemic cerebrovascular disease (MESIA): A randomized clinical trial
    Lv, Xuxian
    Liu, Xudong
    Peng, Yanfang
    Li, Wenbin
    Wang, Jianing
    Chen, Xiaofeng
    Lei, Junjie
    Tang, Chaogang
    Luo, Shijian
    Mai, Weihua
    Cai, Yiming
    Fan, Qian
    Liu, Chenhao
    Zhang, Lei
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2024, 33 (05):
  • [34] EZETIMIBE INDUCED SEVERE RHABDOMYOLYSIS AFTER LONGSTANDING HIGH-INTENSITY STATIN THERAPY
    Yukselen, Zeynep
    Mohamed, Ahmed
    Filiberti, Allen W.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 3308 - 3308
  • [35] Combination of low- or moderate-intensity statin and ezetimibe vs. high-intensity statin monotherapy on primary prevention of cardiovascular disease and all-cause death: a propensity-matched nationwide cohort study
    Jun, Ji Eun
    Jeong, In-Kyung
    Ahn, Kyu Jeong
    Chung, Ho Yeon
    Hwang, You-Cheol
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2024, 31 (10) : 1205 - 1213
  • [36] Is High-Intensity Statin Therapy Associated With Lower Statin Adherence Compared With Low- to Moderate-Intensity Statin Therapy? Implications of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guidelines
    Virani, Salim S.
    Woodard, LeChauncy D.
    Akeroyd, Julia M.
    Ramsey, David J.
    Ballantyne, Christie M.
    Petersen, Laura A.
    CLINICAL CARDIOLOGY, 2014, 37 (11) : 653 - 659
  • [37] Clinical outcome of statin plus ezetimibe versus high-intensity statin therapy in patients with acute myocardial infarction propensity-score matching analysis
    Ji, Mi Seon
    Jeong, Myung Ho
    Ahn, Young Keun
    Kim, Sang Hyung
    Kim, Young Jo
    Chae, Shung Chull
    Hong, Taek Jong
    Seong, In Whan
    Chae, Jei Keon
    Kim, Chong Jin
    Cho, Myeong Chan
    Rha, Seung-Woon
    Bae, Jang Ho
    Seung, Ki Bae
    Park, Seung Jung
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 225 : 50 - 59
  • [38] Combination of ezetimibe and moderate-intensity statin for patients with atherosclerotic cardiovascular disease: a paradigm shift in lipid management landscape
    Pedicino, Daniela
    Volpe, Massimo
    EUROPEAN HEART JOURNAL, 2022, 43 (41) : 4227 - 4228
  • [39] Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial
    Kim, Byeong-Keuk
    Hong, Sung-Jin
    Lee, Yong-Joon
    Hong, Soon Jun
    Yun, Kyeong Ho
    Hong, Bum-Kee
    Heo, Jung Ho
    Rha, Seung-Woon
    Cho, Yun-Hyeong
    Lee, Seung-Jun
    Ahn, Chul-Min
    Kim, Jung-Sun
    Ko, Young-Guk
    Choi, Donghoon
    Jang, Yangsoo
    Hong, Myeong-Ki
    LANCET, 2022, 400 (10349): : 380 - 390